THE HUMAN villous trophoblast is composed of the cytotrophoblast (C-cell) and the syncytiotrophoblast (S-cell). C-cells, which have a proliferative character, fuse and differentiate into multinucleated S-cells [1] [2] [3] . The non-proliferative Scell possesses essential functions such as production and secretion of steroid and protein hormones for the maintenance of pregnancy [4] [5] [6] . Although the control mechanism in the trophoblast has not yet been elucidated, there have been reports that differentiation and proliferation in some mammalian cells are induced by a mechanism ofreceptor-mediated endocytosis of epidermal growth factor (EGF) [7] , which is capable of stimulating hCG secretion by cultured human choriocarcinoma cells [8] and perifused human placenta [9] . The cell membrane of the human S-cell is rich in receptors for a number of growth factors including those for EGF [7] , insulin [10] , and the family of insulin-like growth factors (IGFs): IGF-I and IGF-II [11, 12] , and somatomedin A and C [13, 14] .
In previous studies, we demonstrated that human placental trophoblasts contain nuclear 3, 5, 3' triiodo-L-thyronine (T3) binding sites biochemically similar to those isolated from rat liver [ 15] , and that these binding sites are mainly localized in the nuclei of C-cells [ 16] . Furthermore, in our culture system for trophoblastic cells the initially harvested 
C-cells changed morphologically
and functionally into S-cells as the incubation time increased up to 120 h [ 16] .
EGF stimulates hCG secretion in trophoblast [17, 18] . Human placenta and isolated trophoblast cells are rich in EGF receptor [19] . It is suggested that EGF should perform possible physiological roles in feto-placental development.
From the viewpoint of the mechanism of action of growth factors, the present study was undertaken to elucidate any differences in action between T3 and EGF, focusing on human term placental trophoblasts which morphologically and functionally change as incubation time increases. Immunocytochemical staining of the cultured cells The Biotin-Streptavidin A Amplified System Kit (Biogenex Lab., U.S.A.) was used according to the biotin-streptavidin-peroxidase complex method. Mouse anti-human EGF monoclonal antibody and mouse anti-EGF receptor monoclonal antibody (Transformation Research, Inc., U.S.A.) were used as the primary antibodies, and both diluted at 1:1,000. The Percoll-purified mononuclear cells and the cultured cells attached to the slides were stained with hematoxylin and eosin. The residual cells were prepared for immunocytochemical staining. Non-specific immunoglobulin binding sites were blocked by 30min preincubation with 5% goat serum. Non-immune rabbit serum as the control was applied for 60min.
Biotin-linked mouse immunoglobulin was used for the second antibody.
Results
As shown in Fig. 1 As shown in Fig. 2 , the rate of secretion of hCG into the media by the cultured cells between 72 and 96 h of incubation was dose-dependently stimulated by 10-10 -10-8 M T3. However, a higher concentration (10-7 M) T3 suppressed hCG secretion as compared to the control level (p < 0.01). EGF (0.1-100ng/ml) also stimulated hCG secretion (at least p< 0.05). The maximum stimulation was observed at 10-8 M T3 or 10ng/ml EGF (p< 0.01, respectively). Any concentration of T3 or EGF used in the present study induced an increase in neither the total number of nuclei nor DNA content, and no further morphological changes in the cultured cells were seen (data not shown).
Next, the initially harvested C-cells were treated with 10-8 M T3 or 10ng/ml EGF for the first half ( 3-b) .
The initially harvested C-cells were positively stained and the multinucleated S-cells cultured for 72h were negatively stained with anti-EGF antibody. On the other hand, anti-EGF receptor antibody reacted positively with S-cells and negatively with C-cells (Fig. 4) .
Discussion
As discussed in the previous paper [ 16] and also A_.t term, the S-cells are terminally differentiated and no longer have the capacity to divide [25] . It should be further clarified whether thyroid hormone increases EGF receptor and EGF receptor mRNA levels in trophoblast, as mentioned concerning liver [26, 27] . EGF has also been shown to decrease nuclear T3 binding in pituitary GH4 cells in culture [28] . Further investigation of hormone modulation of T3, EGF and their receptors should be of great interest.
Although the present immunocytochemical results cannot be ascribed to a lack of EGF receptors on the initial C-cells, our data may support a part of a similar thesis, proposed by Yamamoto et al. [29] : a paracrine or autocrine control mechanism in which EGF synthesized by C-cells facilitates certain functions, including the induction of EGFreceptor action, of neighboring S-cells or S-cell differentiated from the C-cells themselves. It follows that further studies clarifying EGF synthesis in the C-cell should be undertaken.
